Dr Rao Papineni will deliver “Combinatorial energy based cancer therapeutics” at 17th International Conference for Radiation Research ICRR 2023 Canada.
International Atomic Energy Agency
A special issue of Translational Cancer Research (TCR) on “Applications of Nanotechnology in Radiation Research”, we showcase the innovative and novel approaches in the utility of nanotechnology in Radiation therapy.
PACT&Health is Awarded a Prestigious National Cancer Institute NCI SBIR contract to develop Anti-Cancer Radiation Drug Screening Platform.
Towards Engineered Precision Assays and Poly Pharmacological Cure-Based Cancer Drug/ Therapy Solutions.
To provide a platform for Cancer Biology, Radiation Oncology, and Radiation Biology for utilizing advanced preclinical and translational technologies in improving biomarker database and impact precision cancer treatment globally. PACT & Health established in 2013, further focusses in developing Radiation modifying agents such as radiosensitizers and radioprotectants.
Technological Advancements in External Beam Radiation Therapy (EBRT): An Indispensable Tool for Cancer Treatmenthttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012312/
Development of radiation-triggered phosphor platform for localized activation in combinatory cancer treatment (July, 2021)Proceedings: AACR Annual Meeting 2021; April 10-15, 2021 and May 17-21, 2021; Philadelphia, PA Abstract A defined spatial and temporal control of induction of toxicity in response to external ionizing radiation such...
Inhibition of pseudo SARS-CoV-2 binding activity of a anti-cancer polypharmacological agent analogs (July, 2021)Proceedings: AACR Annual Meeting 2021; April 10-15, 2021 and May 17-21, 2021; Philadelphia, PA Abstract Severe acute respiratory syndrome coronavirus (SARS-CoV-2), a single-stranded RNA virus with largest genomes (∼ 29,800 bases) of...